PL177140B1 - Izoindole i sposób wytwarzania izoindoli - Google Patents

Izoindole i sposób wytwarzania izoindoli

Info

Publication number
PL177140B1
PL177140B1 PL93320206A PL32020693A PL177140B1 PL 177140 B1 PL177140 B1 PL 177140B1 PL 93320206 A PL93320206 A PL 93320206A PL 32020693 A PL32020693 A PL 32020693A PL 177140 B1 PL177140 B1 PL 177140B1
Authority
PL
Poland
Prior art keywords
group
formula
ene
azabicyclo
carbon atoms
Prior art date
Application number
PL93320206A
Other languages
English (en)
Polish (pl)
Inventor
Thomas Philipps
Stephan Bartel
Andreas Krebs
Uwe Petersen
Thomas Schenke
Klaus-Dieter Bremm
Rainer Endermann
Karl G. Metzger
Burkhard Mielke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PL177140B1 publication Critical patent/PL177140B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
PL93320206A 1992-09-15 1993-09-14 Izoindole i sposób wytwarzania izoindoli PL177140B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4230804A DE4230804A1 (de) 1992-09-15 1992-09-15 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate

Publications (1)

Publication Number Publication Date
PL177140B1 true PL177140B1 (pl) 1999-09-30

Family

ID=6467987

Family Applications (3)

Application Number Title Priority Date Filing Date
PL93320206A PL177140B1 (pl) 1992-09-15 1993-09-14 Izoindole i sposób wytwarzania izoindoli
PL93326006A PL177238B1 (pl) 1992-09-15 1993-09-14 Sposób wytwarzania izoindoli
PL93300385A PL177155B1 (pl) 1992-09-15 1993-09-14 Pochodne 7-izoindolinylo-chinolonu i-naftyrydonu i sposób ich wytwarzania

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL93326006A PL177238B1 (pl) 1992-09-15 1993-09-14 Sposób wytwarzania izoindoli
PL93300385A PL177155B1 (pl) 1992-09-15 1993-09-14 Pochodne 7-izoindolinylo-chinolonu i-naftyrydonu i sposób ich wytwarzania

Country Status (27)

Country Link
US (3) US5556979A (enEXAMPLES)
EP (1) EP0588166B1 (enEXAMPLES)
JP (1) JP3199930B2 (enEXAMPLES)
KR (1) KR100288522B1 (enEXAMPLES)
CN (1) CN1044118C (enEXAMPLES)
AT (1) ATE138920T1 (enEXAMPLES)
AU (2) AU668743B2 (enEXAMPLES)
CA (2) CA2469296A1 (enEXAMPLES)
CZ (1) CZ288493B6 (enEXAMPLES)
DE (2) DE4230804A1 (enEXAMPLES)
DK (1) DK0588166T3 (enEXAMPLES)
ES (1) ES2088618T3 (enEXAMPLES)
FI (1) FI934004A7 (enEXAMPLES)
GR (1) GR3020484T3 (enEXAMPLES)
HU (1) HU222348B1 (enEXAMPLES)
ID (1) ID23959A (enEXAMPLES)
IL (1) IL106990A (enEXAMPLES)
MX (1) MX9305256A (enEXAMPLES)
MY (1) MY131373A (enEXAMPLES)
NO (1) NO304944B1 (enEXAMPLES)
NZ (2) NZ248631A (enEXAMPLES)
PL (3) PL177140B1 (enEXAMPLES)
RU (1) RU2111964C1 (enEXAMPLES)
SK (1) SK282274B6 (enEXAMPLES)
TW (1) TW316899B (enEXAMPLES)
UA (1) UA35562C2 (enEXAMPLES)
ZA (1) ZA936759B (enEXAMPLES)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2112165C (en) * 1992-12-25 2003-04-08 Makoto Takemura Bicyclic amine derivatives
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
US5508424A (en) * 1993-03-26 1996-04-16 Ortho Pharmaceutical Corporation 4-arylisoindole analgesics
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE4418510A1 (de) * 1994-05-27 1995-11-30 Bayer Ag 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE4435479A1 (de) 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19500792A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19506535A1 (de) * 1995-02-09 1996-08-14 Bayer Ag 1,6-Naphthyridoncarbonsäurederivate
PT726270E (pt) * 1995-02-09 2001-08-30 Bayer Ag Derivados do acido 1,6-naftiridonocarboxilico
DE19722812C2 (de) * 1997-05-30 2003-02-13 Bat Cigarettenfab Gmbh Ultraleicht-Koaxialcigarette mit mehrteiligem Filter
RU2193558C2 (ru) 1997-09-15 2002-11-27 Дзе Проктер Энд Гэмбл Компани Производные хинолона и фармацевтическая композиция на их основе
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
RU2255938C2 (ru) * 1999-03-10 2005-07-10 Дайити Фармасьютикал Ко., Лтд. Производные аминометилпирролидина, имеющие ароматические заместители
US6667406B1 (en) * 1999-03-10 2003-12-23 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of complex reduced isoindole, isooxyindole and isooxyquinoline libraries
EP1341781B1 (en) 2000-12-14 2005-09-14 The Procter & Gamble Company Antimicrobial quinolones
IL155678A0 (en) 2000-12-14 2003-11-23 Procter & Gamble Antimicrobial 2-pyridones, their compositions and uses
PL2001862T3 (pl) * 2006-03-28 2011-09-30 Warner Chilcott Co Llc Jabłczany oraz odmiany polimorficzne kwasu (3S,5S)-7-[3-amino-5-metylo-piperydynylo]-1-cyklopropylo-1,4-dihydro-8-metoksy-4-okso-3-chinolinokarboksylowego
MX2008012488A (es) * 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
US7528264B2 (en) * 2006-03-28 2009-05-05 The Procter & Gamble Company Hydride reduction process for preparing quinolone intermediates
RU2769675C2 (ru) * 2020-07-21 2022-04-04 Сергей Иванович Орлов Устройство передачи информации через барьер гальванической развязки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines
WO1992012146A1 (en) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
DE4120646A1 (de) * 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
US5468742A (en) * 1991-07-19 1995-11-21 Bayer Aktiengesellschaft 8-vinyl- and 9-ethinyl-quinolone-carboxylic acids
DE4123918A1 (de) * 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
DE4408212A1 (de) * 1994-03-11 1995-09-14 Bayer Ag 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren

Also Published As

Publication number Publication date
ATE138920T1 (de) 1996-06-15
KR940007027A (ko) 1994-04-26
UA35562C2 (uk) 2001-04-16
CA2469296A1 (en) 1994-03-16
JPH06263755A (ja) 1994-09-20
AU4492793A (en) 1994-03-24
NO933132L (no) 1994-03-16
MX9305256A (es) 1995-01-31
PL177155B1 (pl) 1999-09-30
CZ190393A3 (en) 1994-04-13
NZ248631A (en) 1996-01-26
GR3020484T3 (en) 1996-10-31
US5739339A (en) 1998-04-14
PL177238B1 (pl) 1999-10-29
MY131373A (en) 2007-08-30
HUT65216A (en) 1994-05-02
NZ280374A (en) 1996-08-27
FI934004A0 (fi) 1993-09-13
US5556979A (en) 1996-09-17
HU222348B1 (hu) 2003-06-28
NO933132D0 (no) 1993-09-02
ZA936759B (en) 1994-04-11
CA2105923A1 (en) 1994-03-16
RU2111964C1 (ru) 1998-05-27
US6018054A (en) 2000-01-25
SK99093A3 (en) 1994-04-06
TW316899B (enEXAMPLES) 1997-10-01
DE4230804A1 (de) 1994-03-17
JP3199930B2 (ja) 2001-08-20
KR100288522B1 (ko) 2001-05-02
CN1044118C (zh) 1999-07-14
PL300385A1 (en) 1994-03-21
CA2105923C (en) 2004-12-28
DK0588166T3 (da) 1996-10-07
DE59302809D1 (de) 1996-07-11
EP0588166B1 (de) 1996-06-05
ID23959A (id) 1994-03-10
NO304944B1 (no) 1999-03-08
AU682134B2 (en) 1997-09-18
ES2088618T3 (es) 1996-08-16
CN1087634A (zh) 1994-06-08
SK282274B6 (sk) 2002-01-07
HU9302593D0 (en) 1993-11-29
EP0588166A3 (enEXAMPLES) 1994-04-27
FI934004L (fi) 1994-03-16
IL106990A (en) 1997-02-18
EP0588166A2 (de) 1994-03-23
FI934004A7 (fi) 1994-03-16
AU6205996A (en) 1996-10-24
CZ288493B6 (en) 2001-06-13
AU668743B2 (en) 1996-05-16
IL106990A0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
PL177140B1 (pl) Izoindole i sposób wytwarzania izoindoli
US10745404B2 (en) Process for the synthesis of E1 activating enzyme inhibitors
JP2020189861A (ja) チトクロームｐ４５０モノオキシゲナーゼの阻害剤およびそれに関わる中間体
RU2131430C1 (ru) Производные пиридобензоксадиазина, смесь их изомеров или отдельные изомеры, их гидраты и соли
AU2013204601B2 (en) Process for the synthesis of E1 activating enzyme inhibitors
EP2487157A1 (en) Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use
HK1178895B (en) Process for the synthesis of e1 activating enzyme inhibitors
HK1143592B (en) Process for the synthesis of e1 activating enzyme inhibitors
HK1178167B (en) Intermediates for the synthesis of e1 activity activating enzyme inhibitors
HK1178167A (en) Intermediates for the synthesis of e1 activity activating enzyme inhibitors
HK1178895A (en) Process for the synthesis of e1 activating enzyme inhibitors